BioXcel Therapeutics (BTAI) Current Assets (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Current Assets of $33.9 million for Q1 2026, down 10.24% year-over-year from $37.8 million in Q1 2025, and down 24.12% quarter-over-quarter from $44.7 million in Q4 2025.
BioXcel Therapeutics (BTAI) Current Assets (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Current Assets history runs 10 years deep, the most recent figure standing at $33.9 million for Q1 2026.
- In Q1 2026, Current Assets fell 10.24% year-over-year to $33.9 million; the TTM figure through Mar 2026 stood at $33.9 million (down 10.24% YoY), while the FY2025 annual figure was $44.7 million, up 19.5% from the prior year.
- Current Assets for Q1 2026 stood at $33.9 million, down from $44.7 million in the prior quarter.
- The five-year high for Current Assets was $244.9 million in Q2 2022, with the low at $25.2 million in Q2 2025.
- The 5-year median for Current Assets is $72.1 million (2023), against an average of $105.9 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets sank 64.44% in 2023, then climbed 19.5% in 2025.
- BioXcel Therapeutics' Current Assets stood at $202.9 million in 2022, then tumbled by 64.44% to $72.1 million in 2023, then sank by 48.17% to $37.4 million in 2024, then gained by 19.5% to $44.7 million in 2025, then fell by 24.12% to $33.9 million in 2026.
- Business Quant data shows BTAI's Current Assets at $33.9 million in Q1 2026, $44.7 million in Q4 2025, and $44.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | 28.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.70 Mn |
| Mar 31, 2026 | 33.91 Mn |
| Dec 31, 2025 | 44.69 Mn |
| Sep 30, 2025 | 44.40 Mn |
| Jun 30, 2025 | 25.24 Mn |
| Mar 31, 2025 | 37.78 Mn |
| Dec 31, 2024 | 37.39 Mn |
| Sep 30, 2024 | 47.79 Mn |
| Jun 30, 2024 | 64.18 Mn |
| Mar 31, 2024 | 80.92 Mn |
| Dec 31, 2023 | 72.14 Mn |
| Sep 30, 2023 | 98.74 Mn |
| Jun 30, 2023 | 138.24 Mn |
| Mar 31, 2023 | 177.27 Mn |
| Dec 31, 2022 | 202.87 Mn |
| Sep 30, 2022 | 241.66 Mn |
| Jun 30, 2022 | 244.92 Mn |
| Mar 31, 2022 | 207.56 Mn |
| Dec 31, 2021 | 236.81 Mn |
| Sep 30, 2021 | 256.93 Mn |